Abbott Laboratories vs Idexx Laboratories
Abbott Laboratories (ABT) and Idexx Laboratories (IDXX) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $181B
- Last close
- $104.48
- 12 months
- −19.6%
- Market value
- $55B
- Last close
- $698.47
- 12 months
- +4.2%
At a glance
- By market value, Abbott Laboratories ($181.0B) is about 3.3 times Idexx Laboratories ($55.0B).
- Over the last 12 months Abbott Laboratories's share price moved −19.6% and Idexx Laboratories's +4.2%; against the S&P 500 that is −30.3 points and −6.4 points.
- In their last fiscal years Abbott Laboratories kept 14.7% of revenue as net income and Idexx Laboratories 24.6%.
- In the last 90 days insiders reported 0 open-market purchases at Abbott Laboratories and 0 at Idexx Laboratories; members of Congress disclosed 3 trades in Abbott Laboratories and 0 in Idexx Laboratories.
- Next results: Abbott Laboratories Jan 20, 2027, Idexx Laboratories Feb 1, 2027.
Share price over the last 12 months
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Abbott Laboratories ABTNYSE · Health Care Equipment | Idexx Laboratories IDXXNASDAQ · Health Care Equipment | |
|---|---|---|
| Size and profitability | ||
| Market value | $181B | $55B |
| Revenue, last fiscal year | $44.3B | $4.3B |
| Net income, last fiscal year | $6.52B | $1.06B |
| Net marginNet income as a share of revenue | 14.7% | 24.6% |
| Free cash flow | $7.39B | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Abbott Laboratories against
Common questions
How is Abbott Laboratories different from Idexx Laboratories?
Abbott Laboratories (ABT) is in Health Care Equipment on NYSE, with $44.3B of revenue in its last fiscal year and a net margin of 14.7%. Idexx Laboratories (IDXX) is in Health Care Equipment on NASDAQ, with $4.3B of revenue in its last fiscal year and a net margin of 24.6%. Both are in the same industry, so the gap is mostly one of size and profitability. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Abbott Laboratories and Idexx Laboratories compare in size?
Abbott Laboratories has the larger market value: Abbott Laboratories $181B and Idexx Laboratories $55B, at the last close.
Whose share price rose more over the last 12 months, ABT or IDXX?
Over the last 12 months Abbott Laboratories moved −19.6% and Idexx Laboratories +4.2%. Past price moves say nothing about the future.
Which has had more insider buying, Abbott Laboratories or Idexx Laboratories?
Since 2006, Abbott Laboratories insiders reported 377 open-market purchases against 24 for Idexx Laboratories. These are counts of what was filed, not a view on either stock.
Do members of Congress trade ABT or IDXX?
In the last 12 months, members of Congress disclosed 28 trades in Abbott Laboratories (ABT) and 2 in Idexx Laboratories (IDXX).
When did insiders last buy ABT and IDXX?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Abbott Laboratories pageIdexx Laboratories pageRare insider trades this weekAll comparisons
https://oqro.io/compare/abt-vs-idxx







